Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 5 | 2023 | 111 | 0.830 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2023 | 628 | 0.710 |
Why?
|
| Lymphocytes | 1 | 2019 | 118 | 0.640 |
Why?
|
| Neutrophils | 1 | 2019 | 131 | 0.640 |
Why?
|
| DNA Mismatch Repair | 5 | 2024 | 25 | 0.620 |
Why?
|
| Genome-Wide Association Study | 8 | 2023 | 333 | 0.580 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 145 | 0.580 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 190 | 0.560 |
Why?
|
| Colonic Neoplasms | 4 | 2024 | 186 | 0.470 |
Why?
|
| Colorectal Neoplasms | 6 | 2015 | 441 | 0.380 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 128 | 0.380 |
Why?
|
| Germ-Line Mutation | 3 | 2020 | 57 | 0.370 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 1502 | 0.340 |
Why?
|
| Glucuronosyltransferase | 2 | 2019 | 25 | 0.320 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 34 | 0.320 |
Why?
|
| Genotype | 7 | 2020 | 730 | 0.270 |
Why?
|
| Registries | 7 | 2020 | 335 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2023 | 767 | 0.260 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2012 | 18 | 0.260 |
Why?
|
| Aged | 16 | 2024 | 6741 | 0.240 |
Why?
|
| Middle Aged | 17 | 2024 | 10129 | 0.220 |
Why?
|
| Humans | 31 | 2024 | 37093 | 0.210 |
Why?
|
| Female | 24 | 2024 | 20969 | 0.210 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 275 | 0.200 |
Why?
|
| Odds Ratio | 3 | 2019 | 534 | 0.190 |
Why?
|
| Nicotine | 1 | 2023 | 257 | 0.180 |
Why?
|
| Male | 18 | 2024 | 20025 | 0.170 |
Why?
|
| Receptors, Calcitriol | 1 | 2019 | 69 | 0.160 |
Why?
|
| Nitrosamines | 1 | 2018 | 10 | 0.160 |
Why?
|
| Glucuronides | 1 | 2018 | 11 | 0.160 |
Why?
|
| Estrogen Receptor beta | 2 | 2008 | 40 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 583 | 0.150 |
Why?
|
| Genetic Variation | 3 | 2008 | 387 | 0.140 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 539 | 0.140 |
Why?
|
| Mutation | 3 | 2012 | 1095 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 358 | 0.130 |
Why?
|
| Case-Control Studies | 6 | 2020 | 1130 | 0.130 |
Why?
|
| Logistic Models | 3 | 2019 | 923 | 0.130 |
Why?
|
| Adiposity | 1 | 2017 | 154 | 0.130 |
Why?
|
| Risk Factors | 9 | 2020 | 3562 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 312 | 0.130 |
Why?
|
| DNA Repair | 2 | 2008 | 188 | 0.130 |
Why?
|
| CpG Islands | 1 | 2015 | 97 | 0.120 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 20 | 0.120 |
Why?
|
| Obesity | 2 | 2023 | 1067 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 2379 | 0.110 |
Why?
|
| Prognosis | 4 | 2024 | 739 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 74 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 82 | 0.110 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2026 | 0.110 |
Why?
|
| Smoking | 2 | 2010 | 940 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2013 | 166 | 0.110 |
Why?
|
| Haplotypes | 3 | 2008 | 182 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 14 | 0.100 |
Why?
|
| Survivors | 1 | 2013 | 136 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 92 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2015 | 325 | 0.100 |
Why?
|
| Exercise | 1 | 2017 | 613 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2020 | 1492 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 4 | 0.090 |
Why?
|
| Receptors, Somatostatin | 1 | 2010 | 5 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2010 | 305 | 0.090 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 35 | 0.090 |
Why?
|
| Computational Biology | 1 | 2012 | 293 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 70 | 0.090 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2009 | 1 | 0.090 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 935 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2010 | 106 | 0.090 |
Why?
|
| DNA Glycosylases | 1 | 2008 | 16 | 0.080 |
Why?
|
| Databases, Genetic | 2 | 2020 | 93 | 0.080 |
Why?
|
| Adult | 10 | 2020 | 11712 | 0.080 |
Why?
|
| Asthma | 1 | 2011 | 380 | 0.080 |
Why?
|
| Microsatellite Instability | 3 | 2012 | 43 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 191 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 251 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 229 | 0.070 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 2 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 474 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2005 | 22 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2021 | 85 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 126 | 0.060 |
Why?
|
| Leucovorin | 1 | 2024 | 5 | 0.060 |
Why?
|
| Organoplatinum Compounds | 1 | 2024 | 16 | 0.060 |
Why?
|
| Morbidity | 1 | 2004 | 91 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2024 | 37 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2024 | 34 | 0.060 |
Why?
|
| Cause of Death | 1 | 2004 | 156 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 12 | 0.060 |
Why?
|
| Family Health | 2 | 2015 | 56 | 0.060 |
Why?
|
| Butyric Acid | 1 | 2023 | 18 | 0.060 |
Why?
|
| Cotinine | 1 | 2023 | 43 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 182 | 0.050 |
Why?
|
| Life Style | 1 | 2004 | 308 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 807 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 213 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 142 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 182 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 4268 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 448 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2010 | 753 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2020 | 75 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 77 | 0.050 |
Why?
|
| Family | 2 | 2013 | 173 | 0.050 |
Why?
|
| United States | 3 | 2019 | 4223 | 0.050 |
Why?
|
| Genome, Human | 1 | 2021 | 135 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 120 | 0.040 |
Why?
|
| Pedigree | 2 | 2013 | 79 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2012 | 31 | 0.040 |
Why?
|
| Follistatin | 1 | 2019 | 27 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 59 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 59 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2019 | 94 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 114 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 362 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 893 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 2 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2019 | 180 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 190 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 1908 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 130 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 935 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 34 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 674 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 307 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 98 | 0.040 |
Why?
|
| Heterozygote | 2 | 2008 | 93 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 187 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2017 | 89 | 0.040 |
Why?
|
| Vitamin D | 1 | 2019 | 196 | 0.040 |
Why?
|
| Risk | 2 | 2008 | 267 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 249 | 0.030 |
Why?
|
| Proteins | 1 | 2018 | 369 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 2231 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 5363 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 225 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 854 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2012 | 59 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 93 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2012 | 24 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2012 | 85 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 275 | 0.030 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 4 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 689 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 88 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 441 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 138 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 23 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 33 | 0.020 |
Why?
|
| DNA | 1 | 2013 | 574 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 100 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 178 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 448 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 922 | 0.020 |
Why?
|
| Australia | 1 | 2008 | 76 | 0.020 |
Why?
|
| Canada | 1 | 2008 | 130 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1742 | 0.020 |
Why?
|
| Mothers | 1 | 2010 | 181 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 88 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1033 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 321 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 455 | 0.020 |
Why?
|
| Base Pair Mismatch | 1 | 2005 | 13 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2005 | 8 | 0.020 |
Why?
|
| SEER Program | 1 | 2005 | 91 | 0.020 |
Why?
|
| Neoplasms | 2 | 2005 | 1103 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2004 | 119 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 239 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2004 | 238 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 1378 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 462 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2004 | 451 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 1455 | 0.010 |
Why?
|
| Hawaii | 1 | 2004 | 1929 | 0.010 |
Why?
|